Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02404441
Title Phase I/II Study of PDR001 in Patients With Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | POL | NOR | NLD | LBN | ITA | HUN | FRA | ESP | DEU | CAN

Facility Status City State Zip Country Details
The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Johns Hopkins Baltimore Maryland 21287-0013 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Oregon Health and Science University SC-10 Portland Oregon 97239 United States Details
Sarah Cannon Research Institute SCRI RC Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center MD Anderson PSC Houston Texas 77030 United States Details
Huntsman Cancer Institute Univ. of Utah HCI Salt Lake City Utah 84112-0550 United States Details
Novartis Investigative Site Toronto Ontario M5G 1Z6 Canada Details
Novartis Investigative Site Paris Cedex 10 75475 France Details
Novartis Investigative Site Toulouse Cedex 9 31059 France Details
Novartis Investigative Site Villejuif Cedex 94800 France Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Jena 07740 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Budapest 1134 Hungary Details
Novartis Investigative Site Debrecen 4032 Hungary Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Milano MI 20132 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Modena MO 41124 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Ashrafieh 166830 Lebanon Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Leiden 2300 RC Netherlands Details
Novartis Investigative Site Oslo 0310 Norway Details
Novartis Investigative Site Gdansk 80 952 Poland Details
Novartis Investigative Site Poznan 60-693 Poland Details
Novartis Investigative Site Rzeszow 35-021 Poland Details
Novartis Investigative Site Warszawa 02 781 Poland Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Madrid 28050 Spain Details
Novartis Investigative Site Tainan Taiwan ROC 70403 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Songkhla Hat Yai 90110 Thailand Details
Novartis Investigative Site Bangkok 10330 Thailand Details
Novartis Investigative Site Adana 01250 Turkey Details
Novartis Investigative Site Edirne 22030 Turkey Details
Novartis Investigative Site Istanbul 34303 Turkey Details
Novartis Investigative Site Istanbul 34890 Turkey Details
Novartis Investigative Site Izmir 35040 Turkey Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field